Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies (2024)
Attributed to:
Tropical Infectious Disease Consortium: Expanding and Accelerating Product Development
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2024.01.04.574181
Publication URI: http://dx.doi.org/10.1101/2024.01.04.574181
Type: Preprint